ANDA 72922, held by Pliva. Verapamil Hydrochloride.
As of Nov 16, 2026, ANDA 72922 (Verapamil Hydrochloride), held by Pliva, was first approved by FDA on Mar 1, 1996, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 1, 1996 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Verapamil Hydrochloride240MG ยท tablet, extended release;oral | Verapamil Hydrochloride | Discontinued |
| Oct 31, 2000 | Supplement 1Labeling | Approved | None posted |
| Mar 1, 1996 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters